Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CDK9 antibody (Cyclin-Dependent Kinase 9) (N-Term) Primary Antibody

CDK9 Reactivity: Human IP, IHC, ELISA, WB Host: Rabbit Polyclonal unconjugated
Pubmed (6)
Catalog No. ABIN97135
$628.50
Plus shipping costs $45.00 and $24.00 dry ice
100 μL
local_shipping Shipping to: United States
Delivery in 1 to 2 Business Days
  • Target
    CDK9
    Binding Specificity
    C-Term, N-Term
    • 21
    • 15
    • 14
    • 12
    • 8
    • 8
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Reactivity
    Human
    • 101
    • 67
    • 56
    • 7
    • 6
    • 6
    • 5
    • 3
    • 1
    • 1
    • 1
    Host
    Rabbit
    • 95
    • 6
    • 2
    Clonality
    Polyclonal
    Conjugate
    This CDK9 antibody is un-conjugated
    • 46
    • 7
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Application
    Immunoprecipitation (IP), Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
    • 65
    • 33
    • 26
    • 17
    • 15
    • 11
    • 5
    • 5
    • 4
    • 4
    • 3
    • 1
    • 1
    • 1
    Purification
    Antiserum
    Immunogen
    Multiple synthetic peptides corresponding to and domains of the protein coded by the human gene cdk9 (PITALRE).
  • Application Notes
    This antibody has been tested for use in ELISA, immunoprecipitation, immunohistochemistry and by western blot.  Specific conditions for reactivity should be optimized by the end user. Expect a band at approximately 43 kDa corresponding to CDK9 (PITALRE) by western blotting in the appropriate cell lysate or extract. HeLa cells may be used as a positive control.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
  • MacLachlan, Sang, De Luca, Puri, Levrero, Giordano: "Binding of CDK9 to TRAF2." in: Journal of cellular biochemistry, Vol. 71, Issue 4, pp. 467-78, 1999 (PubMed).

    de Falco, Giordano: "CDK9 (PITALRE): a multifunctional cdc2-related kinase." in: Journal of cellular physiology, Vol. 177, Issue 4, pp. 501-6, 1999 (PubMed).

    Fujinaga, Cujec, Peng, Garriga, Price, Graña, Peterlin: "The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1, and Tat." in: Journal of virology, Vol. 72, Issue 9, pp. 7154-9, 1998 (PubMed).

    Bagella, MacLachlan, Buono, Pisano, Giordano, De Luca: "Cloning of murine CDK9/PITALRE and its tissue-specific expression in development." in: Journal of cellular physiology, Vol. 177, Issue 2, pp. 206-13, 1998 (PubMed).

    Bullrich, MacLachlan, Sang, Druck, Veronese, Allen, Chiorazzi, Koff, Heubner, Croce: "Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer." in: Cancer research, Vol. 55, Issue 6, pp. 1199-205, 1995 (PubMed).

    Graña, De Luca, Sang, Fu, Claudio, Rosenblatt, Morgan, Giordano: "PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 91, Issue 9, pp. 3834-8, 1994 (PubMed).

  • Target
    CDK9
    Alternative Name
    Cdk9 (CDK9 Antibody Abstract)
    Synonyms
    C-2k, CDC2L4, CTK1, PITALRE, TAK, wu:fb22e09, wu:fc06c02, CDK9, CG5179, Dmel\\CG5179, P-TEF, P-TEFb, PTefb, cdk9, c-2k, cdc2l4, ctk1, pitalre, tak, cyclin dependent kinase 9, cyclin-dependent kinase 9 (CDC2-related kinase), cyclin-dependent kinase 9, Cyclin-dependent kinase 9, cyclin-dependent kinase 9 S homeolog, CDK9, cdk9, Cdk9, cdk9.S
    Background
    CDK9 (PITALRE) (also known as cyclin-dependent kinase 9, Serine/threonine-protein kinase PITALRE, C-2K and Cell division cycle 2-like protein kinase 4) is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of S. cerevisiae cdc28, and S. pombe cdc2, and known as important cell cycle regulators. CDK9 (PITALRE) interacts with a conserved domain in the TRAF-C region of the tumor necrosis factor signal transducer TRAF2.   This kinase also was found to be a component of the multiprotein complex TAK/P-TEFb, which is an elongation factor for RNA polymerase II-directed transcription and functions by phosphorylating the C-terminal domain of the largest subunit of RNA polymerase II. This protein forms a complex with and is regulated by its regulatory subunit cyclin T or cyclin K. HIV-1 Tat protein was found to interact with this protein and cyclin T, which suggested a possible involvement of this protein in AIDS. Tat stimulates human HIV-1 viral transcription elongation.  This suggests that cyclin T1/cdk9(PITALRE) is one of the HIV-1 required host cellular cofactors generated during T cell activation.  Cyclin T1/cdk9(PITALRE) is shown to interact with Tat to restore Tat activation in HeLa nuclear extracts depleted of P-TEFb.   The cdk9(PITALRE) activity and cyclin T1 are essential for activation of transcription when tethered to the heterologous Rev response element RNA via the regulator of expression of virion Rev.  CDK9 (PITALRE) is a ubiquitously expressed nuclear protein.
    Synonyms: Cell division cycle 2 like protein kinase 4 antibody, Cell division protein kinase 9 antibody, Cyclin dependent kinase 9 antibody, PITALRE antibody, Serine threonine protein kinase PITALRE antibody, TAK antibody
    Gene ID
    1025, 4502747
    UniProt
    P50750
    Pathways
    Cell Division Cycle
You are here:
help Support